Biotech · Private company
Angion Biomedica Corp
Track this companyFree. Adds Angion Biomedica Corp to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- ANG-3777Phase 3 · Delayed Graft FunctionClinicalTrials.gov · fetched Nov 12, 2026
- ANG-3070Phase 2 · Glomerular DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ANG-3777Phase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- ANG-3777Phase 1 · HemodialysisClinicalTrials.gov · fetched Nov 12, 2026
- ANG-3777 (Supra-therapeutic Dose)Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- ANG-3777 (Therapeutic Dose)Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Moxifloxacin HydrochloridePhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of Safety and Efficacy of ANG-3070 in Chronic Kidney DiseasePHASE2 · UNKNOWN · started Dec 24, 2021ClinicalTrials.gov NCT04939116 · fetched Nov 12, 2026
- Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis SubjectsPHASE1 · UNKNOWN · started Jul 1, 2021ClinicalTrials.gov NCT04958187 · fetched Nov 12, 2026
- Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc IntervalPHASE1 · UNKNOWN · started Jun 1, 2021ClinicalTrials.gov NCT04898907 · fetched Nov 12, 2026
- Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary BypassPHASE2 · UNKNOWN · started Feb 24, 2017ClinicalTrials.gov NCT02771509 · fetched Nov 12, 2026
- Reduce the Severity of DGF in Recipients of a Deceased Donor KidneyPHASE3 · UNKNOWN · started Mar 1, 2016ClinicalTrials.gov NCT02474667 · fetched Nov 12, 2026